RECENT NEWS
Benzinga  6 hrs ago  Comment 
Acorda Therapeutics (Nasdaq: ACOR) today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent Application No. 8,440,703 ("the '703 patent") entitled "Methods of Using Sustained Release Aminopyridine...
Benzinga  May 16  Comment 
NeoStem, Inc. (NYSE: NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy market, today announced the geographic expansion of intellectual property protection around its lead product candidate, AMR-001, with the notice...
BBC News  May 15  Comment 
Protecting your great invention from copycats
Financial Times  May 15  Comment 
Pharmaceutical companies fear that the battle raging in India over generic medicines will inspire emerging economies to change their patent laws
Forbes  May 15  Comment 
The Genetic Literacy Project provides perspective on Monday's Supreme Court ruling in Bowman v Monsanto that a farmer cannot reproduce patented seeds through planting and harvesting without permission of the patent holder—in this case the St....
Cloud Computing  May 14  Comment 
e.Digital Corporation (OTCQB: EDIG), a long standing source of innovation and future-defining patented technologies, announced today that its attorneys have successfully secured new patent license agreements for technologies embodied in its...
Benzinga  May 14  Comment 
Insmed Incorporated (NASDAQ: INSM), a biopharmaceutical company focused on developing and commercializing an inhaled anti-infective to treat patients battling serious lung diseases in orphan indications that are often life-threatening, today...
Cloud Computing  May 14  Comment 
MOUNTAIN VIEW, Calif. , May 14, 2013 /PRNewswire/ -- AirTight Networks announces that the United States Patent and Trademark Office ("USPTO") denied Aerohive Networks' request to re-examine AirTight's Marker Packet™ patent (U.S. Patent No....
The Economist  May 13  Comment 
WITHOUT technical standards, life would be a lot more complicated. They make it possible, for example, for computers of all sorts to connect to the internet via Wi-Fi in homes, offices and coffee shops, and for mobile phones of different makes on...
Forbes  May 13  Comment 
This article is by Richard S. Hill, the chairman and interim chief executive of Tessera, a designer of semiconductor miniaturization technologies. He previously served as CEO of Novellus.




 
TOP CONTRIBUTORS

Patents

Patent is the right to ownership,as part of an intellectual property law, where by a person / organization discovers a lesser known concept or invents something new and holds sole intellectual ownership rights to that particular idea. These are usually published / granted after a lot of research and exhaustive verification. Patents are generally registered with United States Patent and Trademark Office, an Agency Of The United States Department Of Commerce, in the United States and The Intellectual Property Office,a division of the Department for Innovation, Universities & Skills in the United Kingdom.

Technological Patents

Pharmaceutical Patents

Pharmaceutical patents protect manufacturers of prescription drugs, prohibiting others from producing a drug during the length of its patent protection. The length of these patents varies in different countries, though they are usually between 15-20 years. In the U.S., a pharmaceutical patent is valid for 20 years. Drug companies usually apply for patent protection before they actually begin producing the drug, opting instead to secure their rights to a particular compound at the beginning of the testing process. By the time a drug comes to market, there may only be 8-10 years of patent protection remaining, which is significantly less than the 20 offered by the patent. Companies often attempt to extend these patents by making slight reformulations of the original compound or proving its effectiveness at treating a condition other than the one for which it was originally granted a patent. This is referred to as "evergreening", a practice which many criticize.

For further information on the process of obtaining pharmaceutical patents and regulatory approval, see Clinical Trials and FDA Approval.

For more information about pharmaceutical patents in relation to generic versions of drugs, see Generic Drugs.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki